文献速递眼底病与葡萄膜炎神经眼科

早期糖尿病视网膜病变蛋白质组学揭示神经退行性脑病相关通路

Proteomic Analysis of Early Diabetic Retinopathy Reveals Mediators of Neurodegenerative Brain Diseases.
PubMed 文献 · Invest Ophthalmol Vis Sci · 2018-01-01

对年龄匹配的尸体视网膜三组(非糖尿病对照5例、无胶质激活糖尿病5例、有胶质激活糖尿病5例)进行蛋白质组学分析,共鉴定2190种蛋白。通路分析显示「THOP1在阿尔茨海默病中的神经保护作用」与「未折叠蛋白反应」通路仅在对照视网膜富集;「多巴胺降解」与「帕金森病信号」仅在伴胶质激活的糖尿病视网膜富集;「神经调节蛋白信号」「突触长时程增强」「淀粉样蛋白加工」在无胶质激活糖尿病视网膜富集。结论认为糖尿病诱导的视网膜神经退行性变与阿尔茨海默病、帕金森病等脑神经退行性疾病共享致病通路。

要点

  • 伴胶质激活糖尿病视网膜富集多巴胺降解与帕金森病信号通路。
  • 无胶质激活糖尿病视网膜富集神经调节蛋白信号、突触长时程增强与淀粉样蛋白加工通路。
  • 对照视网膜独有THOP1神经保护与未折叠蛋白反应通路富集。

核心结论

  • 糖尿病诱导的视网膜神经退行性变与阿尔茨海默病、帕金森病等脑神经退行性疾病共享致病通路。
  • 作者认为研究糖尿病视网膜神经退行性变可能有助于进一步理解糖尿病患者脑内神经退行性过程。

研究设计与样本

  • 对年龄匹配的三组尸体视网膜进行蛋白质组学分析:非糖尿病对照视网膜5例、无胶质激活的糖尿病视网膜5例、有胶质激活的糖尿病视网膜5例。
  • 每组视网膜裂解液合并后行SDS-PAGE凝胶电泳,条带用Orbitrap质谱仪以液相色谱-质谱联用(LC/MS)顺序分析。

主要发现

  • 所有组共鉴定出2190种蛋白。
  • 「THOP1在阿尔茨海默病中的神经保护作用」与「未折叠蛋白反应」通路仅在对照视网膜富集。
  • 「多巴胺降解」与「帕金森病信号」通路仅在伴胶质激活的糖尿病视网膜富集。
  • 「神经调节蛋白信号」「突触长时程增强」与「淀粉样蛋白加工」通路在无胶质激活的糖尿病视网膜富集。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Current evidence suggests that retinal neurodegeneration is an early event in the pathogenesis of diabetic retinopathy. Our main goal was to examine whether, in the diabetic human retina, common proteins and pathways are shared with brain neurodegenerative diseases. METHODS: A proteomic analysis was performed on three groups of postmortem retinas matched by age: nondiabetic control retinas (n = 5), diabetic retinas without glial activation (n = 5), and diabetic retinas with glial activation (n = 5). Retinal lysates from each group were pooled and run on an SDS-PAGE gel. Bands were analyzed sequentially by liquid chromatography-mass spectrometry (LC/MS) using an Orbitrap Mass Spectrometer. RESULTS: A total of 2190 proteins were identified across all groups. To evaluate the association of the identified proteins with neurological signaling, significant signaling pathways belonging to the category "Neurotransmitters and Other Nervous System Signaling" were selected for analysis. Pathway analysis revealed that "Neuroprotective Role of THOP1 in Alzheimer's Disease" and "Unfolded Protein Response" pathways were uniquely enriched in control retinas. By contrast, "Dopamine Degradation" and "Parkinson's Signaling" were enriched only in diabetic retinas with glial activation. The "Neuregulin Signaling," "Synaptic Long Term Potentiation," and "Amyloid Processing" pathways were enriched in diabetic retinas with no glial activation. CONCLUSIONS: Diabetes-induced retinal neurodegeneration and brain neurodegenerative diseases, such as Alzheimer's and Parkinson's diseases, share common pathogenic pathways. These findings suggest that the study of neurodegeneration in the diabetic retina could be useful to further understand the neurodegenerative processes that occur in the brain of persons with diabetes.

来源:Invest Ophthalmol Vis Sci,查看原文。版权归原作者所有。

引用

  1. Sundstrom JM, Hernández C, Weber SR, et al. Proteomic Analysis of Early Diabetic Retinopathy Reveals Mediators of Neurodegenerative Brain Diseases. Invest Ophthalmol Vis Sci. 2018. PMID: 29847632. doi:10.1167/iovs.17-23678

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。